Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l-Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β-l-Ribofuranosyl-1H-Benzimidazole

Although a number of antiviral drugs inhibit replication of Epstein-Barr virus (EBV) in cell culture, and acyclovir (ACV) suppresses replication in vivo, currently available drugs have not proven effective for treatment of EBV-associated diseases other than oral hairy leukoplakia. Benzimidazole ribo...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	J Virol
Asıl Yazarlar:	Zacny, Valerie L., Gershburg, Eduard, Davis, Michelle G., Biron, Karen K., Pagano, Joseph S.
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1999
Konular:	Vaccines and Antiviral Agents
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC104252/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10438815/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.9.7271-7277.1999
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!